Survival in Primary Congenital Pulmonary Lymphangiectasia with Hydrops FetalisLaje P. · Wilson R.D. · Guttenberg M. · Liechty K.W.
Department of General Surgery, The Children’s Hospital of Philadelphia, Philadelphia, Pa., USA
The recent advances in neonatal and pediatric intensive care have changed the outcome of patients with congenital pulmonary lymphangiectasia of different types, including those cases with early neonatal symptoms. However, the patients who present the most severe form of the disease, manifested by in utero hydrops (including those treated by in utero thoracoamniotic shunting to relieve the mediastinal compression), have had an unvaryingly fatal ending in all published reports, with most cases dying before birth, and the few born alive dying during the first days of life. We present a patient with primary congenital pulmonary lymphangiectasia complicated by hydrops fetalis, who was treated in utero, survived the neonatal period after intensive medical and surgical support, and was discharged home at the age of 2 months. She is currently 6 months old, and has minimal signs or symptoms of chronic lung disease. The different aspects of the management of congenital pulmonary lymphangiectasia are discussed in this report, together with a review of the literature.
© 2008 S. Karger AG, Basel
Received: April 25, 2007
Accepted after revision: June 30, 2007
Published online: August 28, 2008
Number of Print Pages : 5
Number of Figures : 4, Number of Tables : 0, Number of References : 10
Fetal Diagnosis and Therapy (Clinical Advances and Basic Research)
Vol. 24, No. 3, Year 2008 (Cover Date: October 2008)
Journal Editor: Holzgreve W. (Basel), Evans M.I. (New York, N.Y.), Uzan S. (Paris), Michejda M. (Washington, D.C.), Pringle K.C. (Wellington)
ISSN: 1015–3837 (Print), eISSN: 1421–9964 (Online)
For additional information: http://www.karger.com/FDT